Singapore Neurostimulation Devices Market Size & Outlook

The neurostimulation devices market in Singapore is expected to reach a projected revenue of US$ 270.5 million by 2030. A compound annual growth rate of 14.7% is expected of Singapore neurostimulation devices market from 2024 to 2030.
Revenue, 2023 (US$M)
$103.4
Forecast, 2030 (US$M)
$270.5
CAGR, 2024 - 2030
14.7%
Report Coverage
Singapore

Singapore neurostimulation devices market highlights

  • The Singapore neurostimulation devices market generated a revenue of USD 103.4 million in 2023 and is expected to reach USD 270.5 million by 2030.
  • The Singapore market is expected to grow at a CAGR of 14.7% from 2024 to 2030.
  • In terms of segment, spinal cord stimulator was the largest revenue generating product in 2023.
  • Sacral Nerve Stimulator is the most lucrative product segment registering the fastest growth during the forecast period.


Neurostimulation devices market data book summary

Market revenue in 2023USD 103.4 million
Market revenue in 2030USD 270.5 million
Growth rate14.7% (CAGR from 2023 to 2030)
Largest segmentSpinal cord stimulator
Fastest growing segmentSacral Nerve Stimulator
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSpinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Electric Stimulator
Key market players worldwideMedtronic PLC, LivaNova PLC, Boston Scientific Corp, St. Jude Medical, Nevro Corp


Other key industry trends

  • In terms of revenue, Singapore accounted for 1.6% of the global neurostimulation devices market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China neurostimulation devices market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 482.1 million by 2030.

Spinal cord stimulator was the largest segment with a revenue share of 49.32% in 2023. Horizon Databook has segmented the Singapore neurostimulation devices market based on spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, gastric electric stimulator covering the revenue growth of each sub-segment from 2018 to 2030.


Increasing geriatric population in Singapore is expected to drive market growth during the forecast period. With the growing geriatric population, the demand for public healthcare institutions is rising, leading to an increase in the funds for these institutions. These factors present large untapped growth opportunities for the market in Singapore.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Neurostimulation Devices Market Companies

Name Profile # Employees HQ Website

Singapore neurostimulation devices market size, by product, 2018-2030 (US$M)

Singapore Neurostimulation Devices Market Outlook Share, 2023 & 2030 (US$M)

Singapore neurostimulation devices market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more